Allergenis

Growth Stage

The Next Generation of Food Allergy Testing

Overview

Raised to Date: Raised: $359,714

Total Commitments ($USD)

Platform

StartEngine

Start Date

04/24/2023

Close Date

07/20/2023

Min. Goal
$10,000
Max. Goal
$1,235,000
Min. Investment

$250

Security Type

Equity - Common

Series

Series B

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$5.00

Pre-Money Valuation

$40,000,005

Rolling Commitments ($USD)

Status

Active

Reporting Date

06/10/2023

Days Remaining

40

% of Min. Goal

3,597%

% of Max. Goal

29%

Likelihood of Max
unlikely
Avg. Daily Raise

$7,653

# of Investors

189

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2017

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

High

Capital Intensity

Low

Location

NEW YORK, New York

Business Type

Growth

Allergenis, with a valuation of $40 million, is raising funds on StartEngine. The company uses cutting-edge systems biology and data analytics to provide next-generation food allergy testing. The Allergenis system of testing determines tolerance levels, allergic status, and reaction severity to provide a better-informed quality of life. Currently, Allergenis provides peanut allergic status and threshold testing in 49 states and Washington, DC, and plans to launch milk allergy testing in 2023 and egg allergy testing in 2024. Jim Garner founded Allergenis in September 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1.24 million. The campaign proceeds will be used for sales and marketing, clinical operations, research and development, and general and administrative expenses.

Summary Profit and Loss Statement

FY 2022 FY 2021

Revenue

$74,140

$269,597

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-4,952,594

$-3,422,933

Summary Balance Sheet

FY 2022 FY 2021

Cash

$31,203

$19,639

Accounts Receivable

$4,395

$10,000

Total Assets

$454,522

$368,099

Short-Term Debt

$5,157,434

$1,496,119

Long-Term Debt

$1,050,000

$2,942,000

Total Liabilities

$6,207,434

$4,438,119

Financials as of: 04/24/2023
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Allergenis on StartEngine 2023
Platform: StartEngine
Security Type: Equity - Common
Valuation: $40,000,005
Price per Share: $5.00

Follow company

Follow Allergenis on StartEngine 2023

Buy Allergenis's Deal Report

Allergenis Deal Report

Get KingsCrowd’s comprehensive report on Allergenis including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Allergenis is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Allergenis deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge Pro